Halozyme Therapeutics shares owned by Assetmark
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Assetmark
from 13F filings
Historical chart of Assetmark investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Assetmark
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.4M | 108k | 40.68 |
| 2023-12-31 | $3.9M | 105k | 36.96 |
| 2023-09-30 | $2.3M | 62k | 38.20 |
| 2023-06-30 | $2.8M | 78k | 36.07 |
| 2023-03-31 | $1.4M | 38k | 38.19 |
| 2022-12-31 | $1.7M | 29k | 56.90 |
| 2022-09-30 | $1.0M | 26k | 39.53 |
| 2022-06-30 | $96k | 2.2k | 44.04 |
| 2022-03-31 | $54k | 1.3k | 40.15 |
| 2021-12-31 | $57k | 1.4k | 40.54 |
| 2021-09-30 | $55k | 1.4k | 40.59 |
| 2021-06-30 | $56k | 1.2k | 45.34 |
| 2021-03-31 | $51k | 1.2k | 41.30 |
| 2020-12-31 | $40k | 930 | 43.01 |
| 2015-12-31 | $0 | 15 | 0.00 |
| 2014-12-31 | $2.0k | 200 | 10.00 |